BRIEF-Alexion presents new SBC-103 data in patients with MPS iiiB
July 14, 2016 at 09:25 AM EDT
* Alexion presents new SBC-103 (Rhnaglu enzyme) phase 1/2 data on brain MRI and neurocognitive assessments in patients with mucopolysaccharidosis iiib (MPS IIIB)